From: Nanotechnology advances towards development of targeted-treatment for obesity
Browning agents | Actions | Limitations | Current application | Refs |
---|---|---|---|---|
Dibenzazepine | γ-Secretase inhibitor Inhibit Notch signaling Act in the liver to improve systemic metabolism | Solubility Non-specificity | Anti-depressant | [17] |
Resveratrol | Sirtuin activator | Solubility Stability Metabolic transformation Less bioavailability High metabolism in humans | CVDs | |
Rosiglitazone | PPAR gamma activator | Hydrophobic Solubility | T2D | [12] |